Literature DB >> 18033883

Efficient transplantation via antibody-based clearance of hematopoietic stem cell niches.

Agnieszka Czechowicz1, Daniel Kraft, Irving L Weissman, Deepta Bhattacharya.   

Abstract

Upon intravenous transplantation, hematopoietic stem cells (HSCs) can home to specialized niches, yet most HSCs fail to engraft unless recipients are subjected to toxic preconditioning. We provide evidence that, aside from immune barriers, donor HSC engraftment is restricted by occupancy of appropriate niches by host HSCs. Administration of ACK2, an antibody that blocks c-kit function, led to the transient removal of >98% of endogenous HSCs in immunodeficient mice. Subsequent transplantation of these mice with donor HSCs led to chimerism levels of up to 90%. Extrapolation of these methods to humans may enable mild but effective conditioning regimens for transplantation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18033883      PMCID: PMC2527021          DOI: 10.1126/science.1149726

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  30 in total

1.  Physiological migration of hematopoietic stem and progenitor cells.

Authors:  D E Wright; A J Wagers; A P Gulati; F L Johnson; I L Weissman
Journal:  Science       Date:  2001-11-30       Impact factor: 47.728

2.  Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome.

Authors:  F H Bach; R J Albertini; P Joo; J L Anderson; M M Bortin
Journal:  Lancet       Date:  1968-12-28       Impact factor: 79.321

3.  Immunological reconstitution of sex-linked lymphopenic immunological deficiency.

Authors:  R A Gatti; H J Meuwissen; H D Allen; R Hong; R A Good
Journal:  Lancet       Date:  1968-12-28       Impact factor: 79.321

4.  Fate of chromosome-marked mouse bone marrow cells tranfused into normal syngeneic recipients.

Authors:  H S Micklem; C M Clarke; E P Evans; C E Ford
Journal:  Transplantation       Date:  1968-03       Impact factor: 4.939

5.  Special proliferative sites are not needed for seeding and proliferation of transfused bone marrow cells in normal syngeneic mice.

Authors:  G Brecher; J D Ansell; H S Micklem; J H Tjio; E P Cronkite
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

6.  T cell repertoire development in humans with SCID after nonablative allogeneic marrow transplantation.

Authors:  Marcella Sarzotti; Dhavalkumar D Patel; Xiaojing Li; Daniel A Ozaki; Shui Cao; Scott Langdon; Roberta E Parrott; Katherine Coyne; Rebecca H Buckley
Journal:  J Immunol       Date:  2003-03-01       Impact factor: 5.422

7.  Antibody-facilitated chimeras. Stem cell allotransplantation using antihost major histocompatibility complex monoclonal antibodies instead of lethal irradiation for host conditioning.

Authors:  P Gambel; L H Francescutti; T G Wegmann
Journal:  Transplantation       Date:  1984-08       Impact factor: 4.939

8.  Prevention of genetic anemias in mice by microinjection of normal hematopoietic stem cells into the fetal placenta.

Authors:  R A Fleischman; B Mintz
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

9.  Murine marrow cellularity and the concept of stem cell competition: geographic and quantitative determinants in stem cell biology.

Authors:  G A Colvin; J-F Lambert; M Abedi; C-C Hsieh; J E Carlson; F M Stewart; P J Quesenberry
Journal:  Leukemia       Date:  2004-03       Impact factor: 11.528

10.  Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts.

Authors:  A B Cosimi; R B Colvin; R C Burton; R H Rubin; G Goldstein; P C Kung; W P Hansen; F L Delmonico; P S Russell
Journal:  N Engl J Med       Date:  1981-08-06       Impact factor: 91.245

View more
  164 in total

1.  Cholinergic activation of hematopoietic stem cells: role in tobacco-related disease?

Authors:  Edwin Chang; E Camilla Forsberg; Jenny Wu; Susan S Prohaska; Rich Allsopp; Irving L Weissman; John P Cooke
Journal:  Vasc Med       Date:  2010-10       Impact factor: 3.239

2.  Macrophage-mediated GDNF delivery protects against dopaminergic neurodegeneration: a therapeutic strategy for Parkinson's disease.

Authors:  Kc Biju; Qing Zhou; Guiming Li; Syed Z Imam; James L Roberts; William W Morgan; Robert A Clark; Senlin Li
Journal:  Mol Ther       Date:  2010-06-08       Impact factor: 11.454

Review 3.  Mixed chimerism and split tolerance: mechanisms and clinical correlations.

Authors:  David P Al-Adra; Colin C Anderson
Journal:  Chimerism       Date:  2011 Oct-Dec

4.  Antibody targeting KIT as pretransplantation conditioning in immunocompetent mice.

Authors:  Xingkui Xue; Nancy K Pech; W Christopher Shelley; Edward F Srour; Mervin C Yoder; Mary C Dinauer
Journal:  Blood       Date:  2010-09-02       Impact factor: 22.113

Review 5.  Getting blood from bone: an emerging understanding of the role that osteoblasts play in regulating hematopoietic stem cells within their niche.

Authors:  Yusuke Shiozawa; Russell S Taichman
Journal:  Exp Hematol       Date:  2012-05-26       Impact factor: 3.084

Review 6.  Genetic treatment of a molecular disorder: gene therapy approaches to sickle cell disease.

Authors:  Megan D Hoban; Stuart H Orkin; Daniel E Bauer
Journal:  Blood       Date:  2016-01-12       Impact factor: 22.113

Review 7.  Approaches for analyzing the roles of mast cells and their proteases in vivo.

Authors:  Stephen J Galli; Mindy Tsai; Thomas Marichal; Elena Tchougounova; Laurent L Reber; Gunnar Pejler
Journal:  Adv Immunol       Date:  2015-02-07       Impact factor: 3.543

8.  Anti-human CD117 CAR T-cells efficiently eliminate healthy and malignant CD117-expressing hematopoietic cells.

Authors:  Renier Myburgh; Jonathan D Kiefer; Norman F Russkamp; Chiara F Magnani; Nicolás Nuñez; Alexander Simonis; Surema Pfister; C Matthias Wilk; Donal McHugh; Juliane Friemel; Antonia M Müller; Burkhard Becher; Christian Münz; Maries van den Broek; Dario Neri; Markus G Manz
Journal:  Leukemia       Date:  2020-05-01       Impact factor: 11.528

9.  Functional Niche Competition Between Normal Hematopoietic Stem and Progenitor Cells and Myeloid Leukemia Cells.

Authors:  Chen Glait-Santar; Ronan Desmond; Xingmin Feng; Taha Bat; Jichun Chen; Elisabeth Heuston; Benjamin Mizukawa; James C Mulloy; David M Bodine; Andre Larochelle; Cynthia E Dunbar
Journal:  Stem Cells       Date:  2015-10-05       Impact factor: 6.277

Review 10.  Modulating the stem cell niche for tissue regeneration.

Authors:  Steven W Lane; David A Williams; Fiona M Watt
Journal:  Nat Biotechnol       Date:  2014-08       Impact factor: 54.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.